A study of mood, worry, and suicidal thoughts in people with glioblastoma
Official title: Mental Health and Suicidality in Glioblastoma Patients in Germany
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
This study asks people with glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary about depression, anxiety, and thoughts of suicide.
Read our full plain-language summary
What the trial team says
The aim of the study is to use standardized questionnaires to systematically record influencing factors or predictors for suicidal behavior in glioblastoma patients, particularly with regard to existing depression and anxiety symptoms.
Key facts
- Registry number
- NCT07409584
- Conditions studied
- Glioblastoma (GBM)
Where it is running
This trial lists 6 sites.
-
Germany
- Charite (Berlin)
- University Hospital Knappschaftskrankenhaus Bochum (Bochum)
- University Hospital Essen (Essen)
- University hospital Hamburg Eppendorf (Hamburg)
- University hospital Heidelberg (Heidelberg)
- University hospital Muenster (Münster)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.